HomeOpen Access NewsHealth & Social Care

Health & Social Care

Towards better health for Indigenous Peoples

Indigenous Peoples encounter numerous challenges in exercising their right to health. Lorna Rothery discussed the importance of collaborative and culturally sensitive approaches with Dr Sandra Del Pino, Advisor on Cultural Diversity at PAHO.

Case Study: A priority response plan (PRP) for bio-decontamination

Here, we learn how world leading supplier Bioquell devised a PRP for a Biopharmaceutical Production Facility ensuring high-level bio-decontamination in the event of contamination.

One in four HIV patients experience intimate partner violence

According to the CDC, one in four HIV patients in the United States experience intimate partner violence - which could be anything between physical assault to stalking.

Scientists create blood test for depression and bipolar disorder

Indiana University of Medicine researchers spent four years developing a blood test to identify depression and bipolar disorder - they say this work will bring psychiatry from "the 19th century into the 21st".

Over 50% of healthcare workers report one symptom of PTSD

The US is facing a fourth wave of COVID-19, as emergency healthcare workers across the country continue to face the virus and experience levels of burnout that can lead to PTSD.

Center for Disease Control says surfaces “low-risk” for COVID transmission

New CDC guidelines suggest that surfaces are a "low-risk" for COVID transmission - cleaning surfaces with detergent or soap once a day should be enough to reduce possible virus levels.

A year with COVID-19: What has healthcare learnt?

Chris Norton, Managing Director, UK & Ireland, InterSystems, discusses the NHS’ current challenges, integrated care efforts, and the ways data and technology can be harnessed to inform care today, and in a post-COVID world.

REACT study: Primary school children have highest COVID infection level

New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.

Are gold nanoparticles the next generation of implantable sensors?

Scientists have developed an implantable sensor using gold nanoparticles, which can function in the human body for "several months" to report health changes.

Moderna COVID vaccine rollout begins in UK

The Moderna COVID vaccine will initially be given to patients in Wales - which brings the UK up to three approved vaccines.

Scientists identify deadly new snake species in Asia

Researchers have discovered a deadly new snake species in Asia, which has been named Suzhen's krait after the mythical figure of Bai Su Zhen - a snake goddess who saved a lot of human lives.

Survey finds 30% of people with PCOS rely on online forums for information

There is little mainstream awareness of the condition that impacts one in ten women - currently, 30% of people with Polycystic ovary syndrome (PCOS) rely on online forums for information.

VMIC: A base for worldwide collaboration in the development of vaccines

We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.

Johnson & Johnson factory accident damages 15 million vaccine doses

A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.

UK cancer research sector could lose 20% of funding after Horizon Europe

The Institute of Cancer Research found that UK cancer research sector could lose up to 20% of their funding, after UKRI replaces Horizon Europe.

Scientists find Pfizer vaccine is 100% effective in young adolescents

The company aim to start vaccinating children by September 2021, as clinical trials reveal that Pfizer is 100% effective in those aged 12 to 15.

Moderna and Pfizer vaccines 90% effective in US real-world data

Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders